NDC 33342-0276-07
Darifenacin 7.5 mg/1 TABLET, EXTENDED RELEASE
Macleods Pharmaceuticals Limited
Available — 2-Day Shipping
NDC
33342-0276-07
Generic Name
Darifenacin
Brand Name
Darifenacin
Strength
7.5 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Package Size
—
Labeler
Macleods Pharmaceuticals Limited
FDA Drug Information
Indications & Usage
1 INDICATIONS & USAGE Darifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. Darifenacin extended-release tablet is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. ( 1 )
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Darifenacin Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
More from Macleods Pharmaceuticals Limited →
Browse all Macleods Pharmaceuticals Limited products available at wholesale
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 33342-0276-07 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).